Attention-Deficit/Hyperactivity Disorder

Adv Pediatr. 2016 Aug;63(1):255-80. doi: 10.1016/j.yapd.2016.04.017.

Authors

Alexander K C Leung¹, Kam Lun Hon²

Affiliations

¹ Department of Paediatrics, Alberta Children's Hospital, University of Calgary, #200, 233-16th Avenue North West, Calgary, Alberta T2M 0H5, Canada. Electronic address: aleung@ucalgary.ca.
² Department of Paediatrics, Chinese University of Hong Kong, 6/F, Clinical Sciences Building, Prince of Wales Hospital, Shatin, Hong Kong, China.

PMID: 27426904
DOI: 10.1016/j.yapd.2016.04.017

No abstract available

Keywords: Atomoxetine; Attention-deficit; Behavioral intervention; Educational intervention; Hyperactivity; Stimulants; α(2)-Adrenergic agonists.

Publication types

Review

MeSH terms

Adrenergic Uptake Inhibitors / therapeutic use
Adrenergic alpha-2 Receptor Agonists / therapeutic use
Antidepressive Agents / therapeutic use
Attention Deficit Disorder with Hyperactivity / diagnosis*
Attention Deficit Disorder with Hyperactivity / etiology
Attention Deficit Disorder with Hyperactivity / therapy*
Central Nervous System Stimulants / therapeutic use
Child
Comorbidity
Diagnosis, Differential
Humans
Medical History Taking
Neuropsychological Tests
Parents / education
Physical Examination
Prognosis
Psychotherapy

Substances

Adrenergic Uptake Inhibitors
Adrenergic alpha-2 Receptor Agonists
Antidepressive Agents
Central Nervous System Stimulants